Back to search

CSUniversity San Bernardino

Glucagon-like Peptide-1RA as a Public Health Interventions

Abstract

dc:description.abstract

Glucagon-like peptide receptor agonist (GLP-1RA) medications have become a prominent topic of interest both in clinical medicine and broader societal discussions. Although the medication are relatively new and expensive, ongoing research continues to explore pharmacologic modifications aimed at improving therapeutic effectiveness and prolonged drug half-life. GLP-1RAs have gained significant traction due to their ability to lower glycosylated hemoglobin (A1c) and blood glucose levels in individuals who have been diagnosed with type 2 diabetes (T2D). In addition to glycemic control, evidence suggests its associations with appetite suppression, weight loss, reducing cardiovascular disease, improved renal dysfunction, neuroprotective effects related to neurodegenerative disease such as Alzheimer’s disease, and potential applications in treatment of maladaptive eating behaviors, including binge eating disorder (BED), as well as substance use disorders, including alcohol and nicotine. Common adverse effects include appetite suppression and nausea, often results in weight loss, which has further contributed to the increasing popularity of these medications among individuals seeking remedy for weight management. However, it is critical for individuals who were prescribed GLP-1RAs to understand how to use the medication appropriately, as misuse may lead to adverse health outcomes. Potential risk includes excessive or rapid weight loss and the development or exacerbation of eating disorders and malnutrition. As the popular use of GLP-1RA medication continues to expand, attention to patient education, appropriate prescribing practices, and public health implications are critical considerations. As a result, two public health interventions were identified. The first intervention emphasizes the integration of registered dietitians’ (RD) into the GLP-1RA prescribing process to support nutrition education, screening, and informed decision-making through evidenced-based practice. The second intervention proposes the development of a pilot program to examine the effects of GLP-1RA therapy on compulsive behavior, with the goal of evaluating its potential role as an adjunct to existing substance use treatments. Together, these interventions aim to reduce misinformation, improve patient outcomes, and support healthier populations through a multidisciplinary approach.

Degree

thesis:*
Name thesis:degree_name
Master of Public Health
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Health Science and Human Ecology

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sepeda, Briana
Contributors dc:contributor
  • Dr. Dorothy Chen

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://scholarworks.lib.csusb.edu/etd/2502

Chain of custody

source
Harvested from
CSUniversity San Bernardino
Base URL
scholarworks.lib.csusb.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Sepeda, Briana. Glucagon-like Peptide-1RA as a Public Health Interventions. Thesis thesis, https://scholarworks.lib.csusb.edu/etd/2502